03:34:39 EDT Tue 22 Oct 2024
Enter Symbol
or Name
USA
CA



News for C:VPT from 2023-10-23 to 2024-10-22 - 49 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-10-18 15:27C:VPTVentripoint Diagnostics Ltd (2)0.155News ReleaseVentripoint closes $458,587 first financing tranche
2024-10-15 16:14C:VPTVentripoint Diagnostics Ltd (2)0.155News ReleaseVentripoint extends placements, increases LIFE offering
2024-10-11 10:20C:VPTVentripoint Diagnostics Ltd (2)0.165News ReleaseVentripoint submits VMS+4.0 for EU MDR approval
2024-10-08 15:52C:VPTVentripoint Diagnostics Ltd (2)0.18News ReleaseVentripoint Diagnostics completes three quality audits
2024-09-30 08:16C:VPTVentriPoint Diagnostics Ltd.0.17News ReleaseVentripoint Selected as Trusted Solution for Cardiac Imaging; Featured at the Take Heart Conference
2024-09-20 17:30C:VPTVentripoint Diagnostics Ltd (2)0.17News ReleaseVentripoint closes $300K tranche of debenture offering
2024-09-17 14:45C:VPTVentripoint Diagnostics Ltd (2)0.17News ReleaseVentripoint Diagnostics amends $500,000 financing
2024-09-09 17:53C:VPTVentripoint Diagnostics Ltd (2)0.17News ReleaseVentripoint grants options to buy 2.91M shares
2024-09-09 17:15C:VPTVentripoint Diagnostics Ltd (2)0.17News ReleaseVentripoint hires Empire Relations for IR services
2024-09-09 16:46C:VPTVentripoint Diagnostics Ltd (2)0.17News ReleaseVentripoint to launch reference site program
2024-08-29 17:45C:VPTVentripoint Diagnostics Ltd (2)0.19News ReleaseVentripoint arranges $500,000 private placement
2024-08-29 03:48C:VPTVentripoint Diagnostics Ltd (2)0.19SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-29 03:36C:VPTVentripoint Diagnostics Ltd (2)0.19SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-28 14:23C:VPTVentripoint Diagnostics Ltd (2)0.19News ReleaseVentripoint Diagnostics arranges finacnings
2024-08-21 13:01C:VPTVentripoint Diagnostics Ltd (2)0.185News ReleaseVentripoint Diagnostics receives medical device licence
2024-08-14 18:47C:VPTVentripoint Diagnostics Ltd (2)0.195Private Placement - DebentureVentripoint $184,000 debenture private placement
2024-08-12 16:07C:VPTVentripoint Diagnostics Ltd (2)0.20News ReleaseVentripoint applies for VMS+4.0 Health Canada licence
2024-07-02 15:53C:VPTVentripoint Diagnostics Ltd (2)0.205News ReleaseVentripoint closes $184,000 second tranche of placement
2024-06-27 16:35C:VPTVentripoint Diagnostics Ltd (2)0.205News ReleaseVentripoint to seek TSX-V approval to extend placement
2024-06-24 10:30C:VPTVentriPoint Diagnostics Ltd.0.215News ReleaseVentripoint to Present its AI-enhanced Cardiac Ultrasound Technology to B.C. and Canadian Health Care Leaders at The Data Effect
2024-06-13 12:40C:VPTVentripoint Diagnostics Ltd (2)0.21News ReleaseVentripoint appoints Dobson as marketing director
2024-06-11 11:29C:VPTVentripoint Diagnostics Ltd (2)0.22News ReleaseVentripoint Diagnostics to hold teleconference June 14
2024-05-31 01:25C:VPTVentripoint Diagnostics Ltd (2)0.22SEDAR Interim MD & ASEDAR Interim MD & A
2024-05-31 01:18C:VPTVentripoint Diagnostics Ltd (2)0.22SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-29 20:26C:VPTVentripoint Diagnostics Ltd (2)0.22Private Placement - DebentureVentripoint $941,000 debenture private placement
2024-05-14 16:38C:VPTVentripoint Diagnostics Ltd (2)0.23News ReleaseVentripoint to seek TSX-V OK to extend placement
2024-05-13 13:11C:VPTVentripoint Diagnostics Ltd (2)0.245News ReleaseVentripoint closes $941,000 1st financing tranche
2024-05-06 13:03C:VPTVentripoint Diagnostics Ltd (2)0.25News ReleaseVentripoint Diagnostics submits VMS+4.0 to FDA
2024-05-01 13:57C:VPTVentripoint Diagnostics Ltd (2)0.21News ReleaseVentripoint sells second VMS+ unit to Duke University
2024-04-30 01:50C:VPTVentripoint Diagnostics Ltd (2)0.22SEDAR MD & ASEDAR MD & A
2024-04-30 01:22C:VPTVentripoint Diagnostics Ltd (2)0.22SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-04-11 13:49C:VPTVentripoint Diagnostics Ltd (2)0.22News ReleaseVentripoint arranges $3-million debenture financing
2024-03-28 12:19C:VPTVentripoint Diagnostics Ltd (2)0.225News ReleaseVentripoint Diagnostics outlines quarterly activities
2024-03-04 14:38C:VPTVentripoint Diagnostics Ltd (2)0.28News ReleaseVentripoint Diagnostics releases VMS+3.2
2024-02-13 13:27C:VPTVentripoint Diagnostics Ltd (2)0.305News ReleaseVentripoint appoints Hendriks as partnership executive
2024-02-13 12:18C:VPTVentripoint Diagnostics Ltd (2)0.295News ReleaseVentripoint details adjusted board committees
2024-02-05 12:10C:VPTVentripoint Diagnostics Ltd (2)0.26News ReleaseVentripoint names MacNaught as interim CEO, president
2024-02-01 11:59C:VPTVentripoint Diagnostics Ltd (2)0.26News ReleaseVentripoint provides VMS+ to Medical University Vienna
2024-01-29 11:25C:VPTVentripoint Diagnostics Ltd (2)0.27Shareholders LetterVentripoint CEO Macanovic reviews 2023 operations
2024-01-22 02:24C:VPTVentripoint Diagnostics Ltd (2)0.30News ReleaseVentripoint appoints Mertens to clinical advisory board
2024-01-03 10:48C:VPTVentripoint Diagnostics Ltd (2)0.31News ReleaseVentripoint Diagnostics releases white paper on AI tech
2023-12-12 11:43C:VPTVentripoint Diagnostics Ltd (2)0.255News ReleaseVentripoint to distribute in NA hospitals via A SCEND
2023-12-05 11:41C:VPTVentripoint Diagnostics Ltd (2)0.21News ReleaseVentripoint heart-imaging tech to be presented by Ollie
2023-11-29 20:50C:VPTVentripoint Diagnostics Ltd (2)0.185News ReleaseVentripoint loses $1.17-million in Q3 2023
2023-11-29 18:00C:VPTVentripoint Diagnostics Ltd (2)0.185SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-29 17:54C:VPTVentripoint Diagnostics Ltd (2)0.185SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-24 09:55C:VPTVentripoint Diagnostics Ltd (2)0.135News ReleaseVentripoint Diagnostics to release Q3 results Nov. 29
2023-11-03 11:30C:VPTVentripoint Diagnostics Ltd (2)0.15News ReleaseVentripoint Diagnostics holders OK all matters at AGSM
2023-10-24 13:21C:VPTVentripoint Diagnostics Ltd (2)0.18News ReleaseVentripoint to hold AGSM Nov. 1